| 产品名 | |||
| Tegobuvir (GS-9190, GS-333126) | HCV Protease | HCV感染 | Phase 2 |
| Mericitabine (R-7128) | HCV Protease | HCV感染 | Phase 2 |
| Setrobuvir (ANA598) | HCV Protease | HCV感染 | Phase 2 |
| Pibrentasvir (ABT-530) | HCV Protease | HCV感染 | Phase 3 |
| Valopicitabine (NM283) | HCV Protease | HCV感染 | Phase 2 |
| Resiquimod (R-848, S28463) | Others | 淋巴瘤,光化性角化病 | Phase 2 |
| Resatorvid (TAK-242) | Others | 分布性休克 | Phase 3 |
| GS-9620 | Others | HBV感染 | Phase 2 |
| Semagacestat (LY450139) | Gamma-secretase | 阿尔茨海默病 | Phase 3 |
| Verubecestat (MK-8931) | BACE | 阿尔茨海默病 | Phase 3 |
| AZD3293 (LY3314814) | BACE | 阿尔茨海默病 | Phase 3 |
| Avagacestat (BMS-708163) | Beta Amyloid | 阿尔茨海默病 | Phase 2 |
| MK-0752 | Beta Amyloid | 乳腺癌,胰腺癌 | Phase 1/2 |
| LY2811376 | BACE | 阿尔茨海默病 | Phase 1 |
| LY404039 | GluR | 焦虑症 | Phase 1 |
| Mavoglurant (AFQ056) | GluR | 脆性X综合征 | Phase 2/3 |
| Basimglurant (RO4917523, RG7090) | GluR | 抑郁症 | Phase 2 |
| Decoglurant | GluR | 抑郁症 | Phase 2 |
| Tanespimycin (17-AAG) | HSP (e.g. HSP90) | 黑色素瘤,乳腺癌,骨髓瘤,白血病 | Phase 3 |
